Rinri Therapeutics secures £1.4 million seed funding to advance its novel regenerative cell therapy to treat sensorineural hearing loss Gallery

Rinri Therapeutics secures £1.4 million seed funding to advance its novel regenerative cell therapy to treat sensorineural hearing loss

BioCentury (w/c 20 May) – Boehringer Ingelheim, UCB venture arms seed hearing loss newco Rinri Gallery

BioCentury (w/c 20 May) – Boehringer Ingelheim, UCB venture arms seed hearing loss newco Rinri

Scrip – Boehringer Doubles Down On Deafness With Rinri Backing Gallery

Scrip – Boehringer Doubles Down On Deafness With Rinri Backing

FierceBiotech – EuroBiotech: More Articles of Note Gallery

FierceBiotech – EuroBiotech: More Articles of Note